<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02222519</url>
  </required_header>
  <id_info>
    <org_study_id>2014071801</org_study_id>
    <nct_id>NCT02222519</nct_id>
  </id_info>
  <brief_title>Interaction of Statins and Nondepolarizing Muscle Relaxants</brief_title>
  <official_title>Interaction of Statins and Nondepolarizing Muscle Relaxants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Huang-wei LV</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Hospital of China Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      provide evidence for prevention or reduction muscle pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to determine interaction of statins and nondepolarizing muscle
      relaxant,In order to provide evidence for prevention or reduction muscle pain.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>plasma myoglobin concentration</measure>
    <time_frame>20 minutes after administration</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>muscle pain</measure>
    <time_frame>2 and 24 hours postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum potassium concentration</measure>
    <time_frame>2 and 24 hours postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>plasma creatine phosphokinase concentration</measure>
    <time_frame>2 and 24 hours postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urine myoglobin and onset plus duration of succinylcholine block</measure>
    <time_frame>2 and 24 hours postoperatively</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Statin use group</arm_group_label>
    <description>patients taking statins for at least 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non statin use</arm_group_label>
    <description>no history of taking statin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium</intervention_name>
    <description>Rocuronium 0.6mg/kg iv single dose</description>
    <arm_group_label>Statin use group</arm_group_label>
    <arm_group_label>non statin use</arm_group_label>
    <other_name>Rocuronium Bromide Injection</other_name>
    <other_name>Esmeron</other_name>
    <other_name>http://www.msdchina.com.cn/</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients taking simvastatin, lovastatin, atorvastatin, or pravastatin for at least three
        months.

        Patients not taking simvastatin, lovastatin, atorvastatin, or pravastatin for at least
        three months
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with American Society of Anesthesiologists physical status I-III

          -  Patients taking statins for at least 3 months and those who had never used statins
             were considered to be eligible

        Exclusion Criteria:

          -  Orthopedic

          -  Spinal surgery

          -  Surgery involving extensive muscle manipulation

          -  History of liver and kidney failure

          -  Neuromuscular disease

          -  Susceptibility to or family history of malignant hyperthermia

          -  Extensive denervation of skeletal muscle

          -  Chronic pain syndromes

          -  Taking medications that might interact with the effect of rocuronium or serum
             myoglobin difficult intubation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Huangwei Lv, Professor</last_name>
    <role>Study Director</role>
    <affiliation>the Anesthesiology Department</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>China Medical University</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huang-wei Lv, Professor</last_name>
      <phone>86-024-83283100</phone>
      <email>hwl1998@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Huang-wei LV, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 14, 2014</study_first_submitted>
  <study_first_submitted_qc>August 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 21, 2014</study_first_posted>
  <last_update_submitted>October 22, 2014</last_update_submitted>
  <last_update_submitted_qc>October 22, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 23, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>First Hospital of China Medical University</investigator_affiliation>
    <investigator_full_name>Huang-wei LV</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>statins</keyword>
  <keyword>nondepolarizing muscle relaxants</keyword>
  <keyword>rocuronium</keyword>
  <keyword>myalgia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Hypotonia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
    <mesh_term>Rocuronium</mesh_term>
    <mesh_term>Neuromuscular Nondepolarizing Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

